ELAN PHARMA INTERNATIONAL LIMITED

ANTEGREX

Pharmaceutical preparations for the prevention, treatment and diagnosis of inflammatory disorders, diseases and conditions, and for the prevention, treatment and diagnosis of physiological conditions relating to cell adhesion, signaling and migration;

ANTERAGREN

Pharmaceutical preparations for the prevention, treatment and diagnosis of inflammatory disorders, diseases and conditions, and for the prevention, treatment and diagnosis of physiological conditions relating to cell adhesion, signaling and migration;

DERMAFLEX

DERMA FLEX;SUSTAINED RELEASE DRUG DELIVERY DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF MEDICAMENTS;

ELAN DRUG TECHNOLOGIES

Manufacturing pharmaceutical products for others;DRUG TECHNOLOGIES;Pharmaceutical drug development services; pharmaceutical research and development; consultation services in the field of drug delivery technology and pharmaceutical drug development;

ÉLAN ELAN DRUG TECHNOLOGIES

Manufacturing pharmaceutical products for others;The mark consists of the word elan in lower case letters in the color blue with a green accent above the letter e to the left of a green horizontal line separating the words Elan Drug Technologies to the right in the color blue.;The color(s) green and blue is/are claimed as a feature of the mark.;DRUG TECHNOLOGIES;Pharmaceutical drug development services; pharmaceutical research and development; consultation services in the field of drug delivery technology and pharmaceutical drug development;

FONTION

Pharmaceutical preparations for the prevention, treatment and diagnosis of inflammatory disorders, diseases and conditions, and for the prevention, treatment and diagnosis of physiological conditions relating to cell adhesion, signaling and migration;

IPDAS

multiparticulate controlled release delivery formulation which is used to avoid irritating the gastrointestinal tract and is sold as an integral component of various oral pharmaceuticals;

MABIAZ

Pharmaceutical preparations for the prevention, treatment and diagnosis of inflammatory disorders, diseases and conditions, and for the prevention, treatment and diagnosis of physiological conditions relating to cell adhesion, signaling and migration;

MABRATUS

Pharmaceutical preparations for the prevention, treatment and diagnosis of inflammatory disorders, diseases and conditions, and for the prevention, treatment and diagnosis of physiological conditions relating to cell adhesion, signaling and migration;

MABZAVI

Pharmaceutical preparations for the prevention, treatment and diagnosis of inflammatory disorders, diseases and conditions, and for the prevention, treatment and diagnosis of physiological conditions relating to cell adhesion, signaling and migration;

MIDURA

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF HEADACHES;

NANOCRYSTAL

Manufacture of adjuvant preparations for use in pharmaceutical preparations to the order and/or specifications of others;NANO CRYSTAL;Business marketing consulting services; business management consultation services;Technical consultation and research in the field of pharmaceutical manufacturing; product development consultation; consumer product safety testing and consultation;

NANOCRYSTAL COLLOIDAL DISPERSION

Pharmaceutical preparations, namely adjuvant preparations sold as a component of a full line of pharmaceutical, and ingredients and components thereof, namely ultra-small particle formulations;COLLOIDAL DISPERSION;

NANOFORMULATION

A feature of pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;